These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 39062810)

  • 1. SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice.
    Lee YE; Im DS
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total glucosides of peony improve ovalbumin-induced allergic asthma by inhibiting mast cell degranulation.
    Shou Q; Lang J; Jin L; Fang M; Cao B; Cai Y; Ni Z; Qiu F; Li C; Cao G; Fu H
    J Ethnopharmacol; 2019 Nov; 244():112136. PubMed ID: 31377261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury.
    Chu C; Lu YP; Yin L; Hocher B
    Kidney Blood Press Res; 2019; 44(2):149-157. PubMed ID: 30939483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT2-independent effects of canagliflozin on NHE3 and mitochondrial complex I activity inhibit proximal tubule fluid transport and albumin uptake.
    Albalawy WN; Youm EB; Shipman KE; Trull KJ; Baty CJ; Long KR; Rbaibi Y; Wang XP; Fagunloye OG; White KA; Jurczak MJ; Kashlan OB; Weisz OA
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1041-F1053. PubMed ID: 38660713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.
    Li J; Liu H; Takagi S; Nitta K; Kitada M; Srivastava SP; Takagaki Y; Kanasaki K; Koya D
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32134397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalpol exerts antiallergic effects in IgE/ovalbumin-activated mast cells and a murine model of ovalbumin-induced allergic asthma.
    Chiu MH; Hou TY; Fan CK; Chang JH; Lin CL; Huang SC; Lee YL
    Int Immunopharmacol; 2021 Jul; 96():107782. PubMed ID: 34022666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy.
    Herat LY; Matthews JR; Rakoczy EP; Schlaich MP; Matthews VB
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):83. PubMed ID: 37114550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we go beyond surrogates?
    Drexler A
    J Diabetes; 2017 Nov; 9(11):976-977. PubMed ID: 28692750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for tubular Na
    Onishi A; Fu Y; Patel R; Darshi M; Crespo-Masip M; Huang W; Song P; Freeman B; Kim YC; Soleimani M; Sharma K; Thomson SC; Vallon V
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F712-F728. PubMed ID: 32893663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacology of clinical sodium glucose co-transport protein 2 inhibitors and relationship to suspected adverse drug reactions.
    Matharu K; Chana K; Ferro CJ; Jones AM
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00867. PubMed ID: 34586753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin inhibits autophagy and mitigates airway inflammation and remodelling in mice with ovalbumin-induced allergic asthma.
    Hussein NA; Abdel Gawad HS; Maklad HM; El-Fakharany EM; Aly RG; Samy DM
    Eur J Pharmacol; 2023 Jul; 950():175701. PubMed ID: 37044313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin.
    Philippaert K; Kalyaanamoorthy S; Fatehi M; Long W; Soni S; Byrne NJ; Barr A; Singh J; Wong J; Palechuk T; Schneider C; Darwesh AM; Maayah ZH; Seubert JM; Barakat K; Dyck JRB; Light PE
    Circulation; 2021 Jun; 143(22):2188-2204. PubMed ID: 33832341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sophoricoside from Sophora japonica ameliorates allergic asthma by preventing mast cell activation and CD4
    Kim BH; Lee S
    Biomed Pharmacother; 2021 Jan; 133():111029. PubMed ID: 33254020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting FcεRI/TGF-β signaling pathway.
    Kim YY; Hur G; Lee SW; Lee SJ; Lee S; Kim SH; Rho MC
    Pharmacol Res; 2020 Sep; 159():105027. PubMed ID: 32565308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating the Sodium-Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling.
    Sokolov V; Yakovleva T; Chu L; Tang W; Greasley PJ; Johansson S; Peskov K; Helmlinger G; Boulton DW; Penland RC
    CPT Pharmacometrics Syst Pharmacol; 2020 Apr; 9(4):222-229. PubMed ID: 32064793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
    Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
    PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects.
    Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
    J Pharmacol Sci; 2016 Mar; 130(3):159-69. PubMed ID: 26970780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation.
    Koyani CN; Plastira I; Sourij H; Hallström S; Schmidt A; Rainer PP; Bugger H; Frank S; Malle E; von Lewinski D
    Pharmacol Res; 2020 Aug; 158():104870. PubMed ID: 32434052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin.
    Brady JA; Hallow KM
    J Clin Pharmacol; 2018 Mar; 58(3):377-385. PubMed ID: 29144539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.